Centessa Pharmaceuticals plc (CNTA) Misses Q2 EPS by 1c

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q2 EPS of ($0.40), $0.01 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

You May Also Be Interested In

• Samsara Inc (IOT) call put ratio 4.5 calls to 1 put with a focus on September 4 weekly calls into quarter results
• Victoria’s Secret shares slump 16% on weak Q3 operating income outlook
• BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18